NCT07168200View on ClinicalTrials.gov

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

December 31, 2028

Conditions
Advanced Cervical Cancer
Interventions
DRUG

SHR-1316 Injection

SHR-1316 injection.

DRUG

Cisplatin Injection

Cisplatin injection.

DRUG

Carboplatin Injection

Carboplatin injection.

DRUG

Paclitaxel Injection

Paclitaxel injection.

DRUG

SHR-1316 Placebo Injection

SHR-1316 placebo injection.

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Shanghai Shengdi Pharmaceutical Co., Ltd

INDUSTRY